Literature DB >> 36200122

Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment.

Luiz Fernando Norcia1, Erika Mayumi Watanabe2, Pedro Tadao Hamamoto Filho3, Claudia Nishida Hasimoto1, Leonardo Pelafsky1, Walmar Kerche de Oliveira1, Ligia Yukie Sassaki4.   

Abstract

Polycystic liver disease (PLD) is a clinical condition characterized by the presence of more than 10 cysts in the liver. It is a rare disease Of genetic etiology that presents as an isolated disease or assoc\iated with polycystic kidney disease. Ductal plate malformation, ciliary dysfunction, and changes in cell signaling are the main factors involved in its pathogenesis. Most patients with PLD are asymptomatic, but in 2-5% of cases the disease has disabling symptoms and a significant reduction in quality of life. The diagnosis is based on family history of hepatic and/or renal polycystic disease, clinical manifestations, patient age, and polycystic liver phenotype shown on imaging examinations. PLD treatment has evolved considerably in the last decades. Somatostatin analogues hold promise in controlling disease progression, but liver transplantation remains a unique curative treatment modality.
© 2022 Norcia et al.

Entities:  

Keywords:  hepatomegaly; liver; liver cysts; polycystic liver disease; therapeutics

Year:  2022        PMID: 36200122      PMCID: PMC9528914          DOI: 10.2147/HMER.S377530

Source DB:  PubMed          Journal:  Hepat Med        ISSN: 1179-1535


  254 in total

Review 1.  mTOR signaling in growth control and disease.

Authors:  Mathieu Laplante; David M Sabatini
Journal:  Cell       Date:  2012-04-13       Impact factor: 41.582

2.  Treatment of symptomatic polycystic liver disease: transcatheter super-selective hepatic arterial embolization using a mixture of NBCA and iodized oil.

Authors:  Mao Qiang Wang; Feng Duan; Feng Yong Liu; Zhi Jun Wang; Peng Song
Journal:  Abdom Imaging       Date:  2013-06

3.  Angiogenesis in autosomal-dominant polycystic kidney disease.

Authors:  E Bello-Reuss; K Holubec; S Rajaraman
Journal:  Kidney Int       Date:  2001-07       Impact factor: 10.612

Review 4.  An update on ductal plate malformations and fibropolycystic diseases of the liver.

Authors:  Haris Mirza; Whitney Besse; Stefan Somlo; Jeffrey Weinreb; Barton Kenney; Dhanpat Jain
Journal:  Hum Pathol       Date:  2022-06-28       Impact factor: 3.526

5.  Vasopressin regulates the growth of the biliary epithelium in polycystic liver disease.

Authors:  Romina Mancinelli; Antonio Franchitto; Shannon Glaser; Antonella Vetuschi; Julie Venter; Roberta Sferra; Luigi Pannarale; Francesca Olivero; Guido Carpino; Gianfranco Alpini; Paolo Onori; Eugenio Gaudio
Journal:  Lab Invest       Date:  2016-08-29       Impact factor: 5.662

6.  Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease.

Authors:  Inge A Hoevenaren; Ruth Wester; Robert W Schrier; Kim McFann; R Brian Doctor; Joost P H Drenth; Gregory T Everson
Journal:  Liver Int       Date:  2007-10-09       Impact factor: 5.828

Review 7.  Liver transplantation for adult polycystic liver disease.

Authors:  K Swenson; P Seu; M Kinkhabwala; M Maggard; P Martin; J Goss; R Busuttil
Journal:  Hepatology       Date:  1998-08       Impact factor: 17.425

8.  Whole-exome sequencing reveals LRP5 mutations and canonical Wnt signaling associated with hepatic cystogenesis.

Authors:  Wybrich R Cnossen; René H M te Morsche; Alexander Hoischen; Christian Gilissen; Melissa Chrispijn; Hanka Venselaar; Soufi Mehdi; Carsten Bergmann; Joris A Veltman; Joost P H Drenth
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-24       Impact factor: 11.205

9.  Cholangiocyte autophagy contributes to hepatic cystogenesis in polycystic liver disease and represents a potential therapeutic target.

Authors:  Anatoliy I Masyuk; Tatyana V Masyuk; Maria J Lorenzo Pisarello; Jingyi Francess Ding; Lorena Loarca; Bing Q Huang; Nicholas F LaRusso
Journal:  Hepatology       Date:  2018-02-01       Impact factor: 17.425

10.  Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease.

Authors:  Ming Ma; Xin Tian; Peter Igarashi; Gregory J Pazour; Stefan Somlo
Journal:  Nat Genet       Date:  2013-07-28       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.